Drugs / Infanrix®-IPV+Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00343421 Comparator | Jul 2006 → Jun 2008 | diphtheria, haemophilus infectious disease, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV+Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00343421 ↗ |
| Route | Intramuscular | “0.5 mL each, IM (opposite thigh)” NCT00343421 ↗ |